Rituximab for ANCA-associated Vasculitis (RAVE) Long-Term Follow-Up Study

TerminatedOBSERVATIONAL
Enrollment

67

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

May 15, 2014

Study Completion Date

May 15, 2014

Conditions
Granulomatosis With PolyangiitisMicroscopic Polyangiitis
Interventions
OTHER

Observational

Observational study of subjects previously enrolled in the RAVE trial

Trial Locations (8)

10128

Hospital for Special Surgery, New York

21224

Johns Hopkins University, Baltimore

27710

Duke University, Durham

35294

University of Alabama, Birmingham

44195

The Cleveland Clinic, Cleveland

55905

Mayo Clinic Foundation, Rochester

02118

Boston University, Boston

9713GZ

University Hospital Groningen, Groningen

Sponsors
All Listed Sponsors
collaborator

University of Alabama at Birmingham

OTHER

collaborator

Boston University

OTHER

collaborator

Mayo Clinic

OTHER

collaborator

Duke University

OTHER

collaborator

The Cleveland Clinic

OTHER

collaborator

University Medical Center Groningen

OTHER

lead

Johns Hopkins University

OTHER

NCT01586858 - Rituximab for ANCA-associated Vasculitis (RAVE) Long-Term Follow-Up Study | Biotech Hunter | Biotech Hunter